Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
NBI-1117570 by Neurocrine Biosciences for Cognitive Impairment: Likelihood of Approval
NBI-1117570 is under clinical development by Neurocrine Biosciences and currently in Phase I for Cognitive Impairment. According to GlobalData, Phase...
NBI-1117570 by Neurocrine Biosciences for Schizophrenia: Likelihood of Approval
NBI-1117570 is under clinical development by Neurocrine Biosciences and currently in Phase I for Schizophrenia. According to GlobalData, Phase I...
NBI-1117570 by Neurocrine Biosciences for Psychosis: Likelihood of Approval
NBI-1117570 is under clinical development by Neurocrine Biosciences and currently in Phase I for Psychosis. According to GlobalData, Phase I...